Genetic Advantages in Sports: When Do They Count as “Doping”?
What is the essence of sports, and how does that impact the way doping is defined? The sports world is already preparing for an inevitable wave of “gene-doping” as gene-transfer technologies advance and become more widely available to all ages. On the one side, genetic modifications that improve human performance can be considered enhancements that threaten fair competition. However, gene transfer technologies can be used for a wide range of characteristics, thus blurring the lines between therapy and enhancement. This gray zone requires reflections and decisions on whether there is a moral difference between a genetic advantage that is inherited versus acquired. Could gene-transfer be a way of leveling the playing field? Or does it threaten the essence of sports fundamentally?
Panelist: Sarah Polcz, JSD, MSc, JD (Stanford Law School)
Panelist: Silvia Camporesi, PhD, PhD (King’s College London, University of Vienna)
Moderator: Thomas H. Murray, PhD (The Hastings Center)
Please join fellow audience members for an informal discussion in a Zoom meeting immediately following the forum. The link will be placed in the Zoom Chat during the forum. For those who cannot attend the live event, the forum will be recorded and archived on the ELSIhub Video page. Closed captioning will be provided for live and recorded events.
By registering for an ELSIhub event, attendees agree to abide by the ELSIhub Code of Conduct: https://elsihub.org/news/code-conduct
Click here to register.